| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
cholinergic receptor nicotinic alpha 3 subunit | 0.588 | 0.692 | 1.4E-07 |
|
phenotype | 0.100 | None | 1.000 | 5 | 18 | 2010 | 2017 | ||||||||
|
cholinergic receptor nicotinic alpha 5 subunit | 0.593 | 0.577 | 2.1E-06 |
|
phenotype | 0.100 | None | 1.000 | 4 | 9 | 2010 | 2012 | ||||||||
|
hydroxylysine kinase | 0.769 | 0.346 | 7.3E-06 |
|
phenotype | 0.100 | None | 1.000 | 4 | 13 | 2010 | 2017 | ||||||||
|
proteasome 20S subunit alpha 4 | 0.716 | 0.385 | 0.60 |
|
phenotype | 0.100 | None | 1.000 | 3 | 10 | 2010 | 2010 | ||||||||
|
RAB4B-EGLN2 readthrough (NMD candidate) | 0.641 | 0.654 |
|
phenotype | 0.100 | None | 1.000 | 3 | 2 | 2010 | 2012 | |||||||||
|
BDNF antisense RNA | 0.638 | 0.538 |
|
phenotype | 0.100 | None | 1.000 | 3 | 8 | 2010 | 2012 | |||||||||
|
iron responsive element binding protein 2 | 0.619 | 0.577 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 3 | 33 | 2010 | 2010 | ||||||||
|
cytochrome P450 family 2 subfamily F member 2, pseudogene |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2018 | |||||||||||
|
ADAM metallopeptidase with thrombospondin type 1 motif 7 | 0.666 | 0.577 | 2.3E-14 |
|
phenotype | 0.100 | None | 1.000 | 2 | 17 | 2010 | 2010 | ||||||||
|
brain derived neurotrophic factor | 0.345 | 0.923 | 0.66 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2010 | 2012 | ||||||||
|
BBX high mobility group box domain containing | 0.839 | 0.231 | 0.52 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2009 | 2017 | ||||||||
|
egl-9 family hypoxia inducible factor 2 | 0.604 | 0.731 | 0.72 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2010 | 2012 | ||||||||
|
cholinergic receptor nicotinic beta 4 subunit | 0.644 | 0.423 | 0.14 |
|
phenotype | 0.100 | None | 1.000 | 2 | 53 | 2010 | 2010 | ||||||||
|
mortality factor 4 like 1 | 0.736 | 0.423 | 0.99 |
|
phenotype | 0.100 | None | 1.000 | 2 | 21 | 2010 | 2010 | ||||||||
|
ribosomal protein L18 pseudogene 11 | 0.931 | 0.077 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2010 | 2010 | |||||||||
|
FGGY carbohydrate kinase domain containing | 0.890 | 0.115 | 3.2E-18 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
protein phosphatase 2 phosphatase activator | 0.480 | 0.846 | 0.99 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
polybromo 1 | 0.566 | 0.615 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2017 | 2017 | ||||||||
|
ADAMTS like 3 | 0.729 | 0.346 | 1.4E-19 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
phosphotyrosine interaction domain containing 1 | 0.700 | 0.231 | 3.1E-03 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
PIN2 (TERF1) interacting telomerase inhibitor 1 | 0.587 | 0.692 | 4.6E-09 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
dymeclin | 0.563 | 0.769 | 3.6E-13 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
peptidylprolyl isomerase A | 0.510 | 0.769 | 0.56 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
adhesion G protein-coupled receptor G6 | 0.666 | 0.385 | 6.6E-05 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
mitochondrial ribosomal protein S22 | 0.638 | 0.500 | 1.5E-05 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 |